Amundi’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-69
Closed -$1.02K 1742
2025
Q1
$1.02K Sell
69
-26,425
-100% -$454K ﹤0.01% 2035
2024
Q4
$483K Buy
26,494
+21,036
+385% +$283K ﹤0.01% 1573
2024
Q3
$67.6K Buy
5,458
+917
+20% +$13.5K ﹤0.01% 1814
2024
Q2
$61.8K Sell
4,541
-1,323
-23% -$20.9K ﹤0.01% 1765
2024
Q1
$100K Buy
5,864
+1,735
+42% +$34.7K ﹤0.01% 1766
2023
Q4
$94.6K Hold
4,129
﹤0.01% 1786
2023
Q3
$95K Sell
4,129
-369
-8% -$9.29K ﹤0.01% 1767
2023
Q2
$125K Sell
4,498
-324
-7% -$8.05K ﹤0.01% 1722
2023
Q1
$105K Buy
+4,822
New +$126K ﹤0.01% 1726
2022
Q1
Sell
-6,034
Closed -$141K 1653
2021
Q4
$141K Hold
6,034
﹤0.01% 1527
2021
Q3
$128K Hold
6,034
﹤0.01% 1497
2021
Q2
$100K Buy
+6,034
New +$92.1K ﹤0.01% 1453

Other funds holding CCRN

Amundi's CCRN Position: Q2 2025 in Review

Amundi sold out of Cross Country Healthcare (CCRN) in Q2 2025, closing a stake of 69 shares — an estimated $1.02K sold.

Amundi first reported a position in CCRN in Q2 2021 and held it in 12 quarters. The position peaked at $483K in Q4 2024. 161 funds tracked by Wall St. Rank hold CCRN as of Q2 2025.

  • Amundi reported no remaining Cross Country Healthcare position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 69 Cross Country Healthcare shares in Q2 2025, an estimated $1.02K.
  • Amundi first reported a position in Cross Country Healthcare in Q2 2021 and held it in 12 quarters.
  • Amundi's Cross Country Healthcare position peaked at $483K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.